Outbreak of transient conversions of the QuantiFERON-TB gold in-tube test in laboratory health care worker screenings

Clinical and Vaccine Immunology

Volumn 19, Issue 6, 2012, Pages 954-960

  Zanetti, Caterina ^a   Peracchi, Marta ^b   Zorzi, Diego ^a   Fiorio, Silvia ^a   Fallico, Loredana ^b   Palù, Giorgio ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LABORATORY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SCREENING; TUBERCULOSIS; VALIDITY; WARD;

ADULT; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; TUBERCULOSIS;

EID: 84861740951     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05718-11     Document Type: Article

References (33)

1. Arend SM, et al. 2007. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med. 175:618-627. (Pubitemid 46438947)
2. Barry CE, III, et al. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845- 855.
3. Baussano I, et al. 2011. Tubeculosis among health care workers. Emerg. Infect. Dis. 17:488-494.
4. Cardona P-J. 2010. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch. Immunol. Ther. Exp. 58:7-14.
5. Cellestis. 2011. QuantiFERON-TB Gold: package insert for in vitro diagnostic use. Cellestis Inc. U. S. A., Valencia, CA.
6. Denkinger CM, Dheda K, Pai M. 2011. Guidelines on interferon- γrelease assays for tuberculosis infection: concordance, discordance or confusion? Clin. Microbiol. Infect. 17:806-814.
7. Detjen AK, et al. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin. Vaccine Immunol. 16:1170 -1175.
8. Diel R, et al. 2011. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37:88-99.
9. Ewer K, et al. 2006. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174:831-839. (Pubitemid 44511666)
10. Fleming DO, Hunt DL. 2006. Biological safety: principles and practices, 4th ed. ASM Press, Washington, DC.
11. Hill PC, et al. 2007. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 4:e192. doi:10.1371/journal. pmed.0040192.
12. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings. MMWR Recomm. Rep. 54(RR-17):1-141.
13. Mazurek GH, et al. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54 (RR-15):49-55.
14. Mazurek GH, et al. 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 59 (RR-5):1-25.
15. Menzies D. 1999. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am. J. Resp. Crit. Care Med. 159:15-21. (Pubitemid 29036497)
16. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed). 2007. Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
17. Nardell EA, Wallis RS. 2006. Here today-gone tomorrow: the case for transient acute tuberculosis infection. Am. J. Respir. Crit. Care Med. 174: 734-735. (Pubitemid 44511653)
18. Pai M, et al. 2006. Serial testing of health care workers for tuberculosis using interferon-γ assay. Am. J. Respir. Crit. Care Med. 174:349-355. (Pubitemid 44156616)
19. Pai M, O'Brien R. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 4:e208. doi:10.1371/journal.pmed.0040208.
20. Pai M, et al. 2009. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis. 13:84-92.
21. Pai M. 2010. Spectrum of latent tuberculosis-existing tests cannot resolve the underlying phenotypes. Nat. Rev. Microbiol. 8:242.
22. Rangaka MX, et al. 16 August 2011, posting date. Predictive value of interferon γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 12:zfpg>45-55. doi: 10.1016/S1473-3099(11)70210-9.
23. Repubblica Italiana. 30 April 2008, posting date. Decreto Legislativo 9 aprile, n. 81. Attuazione dell'articolo 1 della legge 3 agosto 2007, n. 123, in materia di tutela della salute e della sicurezza nei luoghi di lavoro. Gazzetta Ufficiale n. 101. Suppl. Ordinario n. 108. Associazione Ambiente e Lavoro, San Giovanni, Italy.
24. Repubblica Italiana. 5 August 2009, posting date. Decreto Legislativo 3 agosto, n. 106. Disposizioni integrative e correttive del decreto legislativo 9 aprile 2008, n. 81, in materia di tutela della salute e della sicurezza nei luoghi di lavoro. Gazzetta Ufficiale n. 180. Suppl. Ordinario n. 142. Associazione Ambiente e Lavoro, San Giovanni, Italy.
25. Ringshausen FC, et al. 2011. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin. Vaccine Immunol. 18:1176-1182.
26. Russo F, Piovesan C, Pozza F, Zanella F, Verizzi E. 2010; 23 November 2011, accession date. Sorveglianze speciali delle malattie infettive anno 2010. http://www.epicentro.iss.it/regioni/veneto/pdf/RappMI2010.pdf. Dipartimento di Prevenzione della Regione del Veneto, Venice, Italy.
27. Schablon A, et al. 2010. Serial testing with an interferon-γ release assay in German healthcare workers.GMSKrankenhhyg. Interdiszip. 5:pii:Doc05. doi:10.3205/dgkh000148.
28. Tuuminen T, Tavast E, Väisänen R, Himberg JJ, Seppälä I. 2010. Assessment of imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis. Clin. Vaccine Immunol. 17:596-601.
29. van Zyl-Smit RN, et al. 2009. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am. J. Respir. Crit. Care Med. 180:49-58.
30. Veerapathran A, et al. 2008. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 3:e1850. doi:10.1371/journal.pone.0001850.
31. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. 2009. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-γ assays. Epidemiol. Infect. 137:1691-1698.
32. Young DB, Gideon HP, Wilkinson RJ. 2009. Eliminating latent tuberculosis. Trends Microbiol. 17:183-188.
33. Zwerling A, et al. 2012. 12 January 2011, posting date. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 67:62-70. doi:10.1136/thx.2010.143180.